Dr. Geeta Gulati, Department of Cardio Oncology, Oslo University Hospital, Ullevaal, Norway “The difficulty of troponin elevation during treatment with check point inhibitors Monthly Webinars FacebookTwitterLinkedinPin It You may also like February 2021 : Optimizing Cancer Survivorship and Cardiovascular outcomes: Gaps and opportunities December 2020 : Cardiac dysfunction in a patient treated with cabozantinib. November 2020: Lung cancer patient with pembrolizumab October 2020 ICOS Monthly Case Study Webinar September 2020 ICOS Monthly Case Study Webinar August 2020 : A case of acute and rapidly progressive RV failure July 2020 Carcinoid Heart Disease secondary to Neuroendocrine Tumors (NET) June 2020: Capecitabine-induced Hypertriglyceridemia: Case Report and Topic Review. May 2020 -“The Promise and Pitfalls of Continuing Trastuzumab in the Presence of Cardiotoxicity” April 2020 Case Review: “Is Oral Chemotherapy Really Safer than IV Chemotherapy? An Osemertinib Cardiotoxicity Case” February 2020 : Special Cardio-Oncology Considerations in Patients with Genetic Syndromes January 2020 : Treating the Treatment: Multi-Organ Toxicities of Fluoropyrimidines and Platinum-based Combination Therapies 123…8»Page 1 of 8
